Related Experiment Videos
[The effect of sermion on brain function in diabetics]
Vrachebnoe Delo
|November 1, 1991
Summary
Sermion (nicergoline) effectively treated central neuropathy in diabetes mellitus patients. This vasoactive drug improved neuropathy symptoms and brain function, as confirmed by electroencephalography and evoked potential tests.
Area of Science:
- Neurology
- Pharmacology
- Endocrinology
Background:
- Diabetes mellitus frequently causes central neuropathy.
- Diabetic neuropathy significantly impacts patients' quality of life and neurological function.
Purpose of the Study:
- To evaluate the efficacy of the vasoactive drug sermion in treating central neuropathy in patients with diabetes mellitus.
- To assess the impact of sermion on neurological function and brain activity in this patient cohort.
Main Methods:
- Clinical assessment of neuropathy symptoms.
- Electroencephalography (EEG) to measure brain electrical activity.
- Evoked potential tests (visual and somatosensory) to evaluate neural pathway function.
Main Results:
- Sermion treatment led to a positive clinical course of neuropathy.
- EEG parameters showed improvement following sermion administration.
- Visual and somatosensory evoked potentials demonstrated enhanced brain function.
Conclusions:
- Sermion is a potential therapeutic option for managing brain complications in diabetic patients.
- The drug positively influences the clinical and electrophysiological aspects of diabetic neuropathy.